ResearcherUniversitätsmedizin RostockNo recent work listed
Florian Bürtin
Matched on ORCID iD 0000-0001-9927-1852; OpenAlex author ID A5032209329. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper
Papers 6
- Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer. Co-author DOI 10.1186/s13578-023-01090-8↗
- HROP68: A rare case of medullary pancreatic cancer-characterization and chemosensitivity of the first patient-derived cell line. Last author DOI 10.3389/fonc.2022.1082927↗
- Biomarkers in Liquid Biopsies for Prediction of Early Liver Metastases in Pancreatic Cancer. Co-author DOI 10.3390/cancers14194605↗
- Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines. Co-author DOI 10.7150/jca.17972↗
- Impact of diabetes type II and chronic inflammation on pancreatic cancer. Co-author DOI 10.1186/s12885-015-1047-x↗
- Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancer. First author DOI 10.1186/s13578-015-0038-6↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dietmar Zechner · 3 shared papers, 2015–2017 · strength 0.21
- Paper Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines. DOI 10.7150/jca.17972↗
- Paper Impact of diabetes type II and chronic inflammation on pancreatic cancer. DOI 10.1186/s12885-015-1047-x↗
- Paper Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancer. DOI 10.1186/s13578-015-0038-6↗
- Brigitte Vollmar · 3 shared papers, 2015–2017 · strength 0.21
- Paper Metformin Inhibits Gemcitabine Induced Apoptosis in Pancreatic Cancer Cell Lines. DOI 10.7150/jca.17972↗
- Paper Impact of diabetes type II and chronic inflammation on pancreatic cancer. DOI 10.1186/s12885-015-1047-x↗
- Paper Characterization of novel carcinoma cell lines for the analysis of therapeutical strategies fighting pancreatic cancer. DOI 10.1186/s13578-015-0038-6↗
- Jens von den Driesch · 1 shared paper, 2022 · strength 0.19
- Yu-Ching Fan · 1 shared paper, 2023 · strength 0.17
- Yuan‐Chin Tsai · 1 shared paper, 2023 · strength 0.17
- Jian-Da Lin · 1 shared paper, 2023 · strength 0.17
- Tina Daunke · 1 shared paper, 2022 · strength 0.13
- Yoshiaki Sunami · 1 shared paper, 2022 · strength 0.13
- Christoph Röcken · 1 shared paper, 2022 · strength 0.13
- Anne‐Sophie Mehdorn · 1 shared paper, 2022 · strength 0.13
- Silje Beckinger · 1 shared paper, 2022 · strength 0.13
- Uwe A. Wittel · 1 shared paper, 2022 · strength 0.13
- Susanne Sebens · 1 shared paper, 2022 · strength 0.13
- Christoph Kahlert · 1 shared paper, 2022 · strength 0.13
- Faik Güntac Uzunoglu · 1 shared paper, 2022 · strength 0.13
- Lars Ivo Partecke · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.